Services Design Development Scientific Advice Project Management QA – Quality Assurance Monitoring Clinical Performance Data Management/eTrials Biostatistics Medical Writing Expert Statement Expertise Pharmacokinetics BA/BE Interactions Oncological trials Ophthalmological trials Inhalatives Transdermal Therapeutic Systems Children Sexual Hormones Therapeutic Expertise Clinical Development Phase I Phase II / Proof of Concept Phase III in OTC Phase III Non-Interventional Magnetic Marker Monitoring Medical Devices Nutrition Studies Clinical Pharmacology Unit Location Plan Capacity Technical Monitoring Ophthalmology Gynaecology Intensive Assessment Unit Clean Room Area Archive About Us Goals and Visions Our Experts Science Quality Library Presentations Library Publications Locations Career News EUFEPS Network on Dermatopharmacy just founded 22nd PKPD Expertentreffen in the heart of the Black Forest 3rd GBHI in Amsterdam: lively discussions and intensive exchange with authorities Meet us in Amsterdam: 3rd GBHI Conference starts soon (12 – 13 April 2018) Meet us in Munich: AGAH Annual Meeting 26 – 27 April 2018 Regorafenib: first in human as eye drops Probanden The SocraTec Family SocraTec C&S SocraMetrics Cooperations
Phase IIb trials FIM Absorption Monitoring Bioequivalence Patch Axis Clinical pharmacology unit Absorption windows Pilot study Data Validation Plan Cough Legal representative First in human Statistical programming Common cold Creativity Non interventional Early phase Intensive assessment station Protocol development Scientific advice Drug Drug Interaction Dermal irritation Phase IIa trials Sample size estimation CDISC FDA CDM Consultancy Lung Transdermal therapeutic system Female adolescents Protocol Biometrics Dry powder inhaler Phase I Biosimilars Phase I Unit Life cycle management Investigators brochure Competence Ophthalmological trials Glaucoma Database Ophthalmology Paediatricians Edema Ocular tolerability Clinical Monitoring GCP training Safety Statistical Analysis Plan Spacious archive CDASH Ovulation inhibition Scientific expertise Design development Inhalatives Standardisation Phase III IB SOP based Phase IV Phase II Healthy subjects Postmenopausal women Dry eye IMPD Central surveillance system Children Pituitary Quality Management System Oncological patients Patient recruitment Pulse oximetry plethysmography MMM Copyright ICF CRA Network Metered dose inhaler Oncology Slit lamp microscopy Training Informed Consent Procedure Steady state Product development US CFR 21 Part 11 Legal Information Post authorisation Gynaecological trials GCP Uveitis Clinical trials Bioavailability Contraception COPD Data Management Plan Expert Source Data Verification Clinical development program ADAM PASS Drug Food Interaction WinNonlin Dose linearity Anaesthesiologist Sensitisation trials US FDA Standard operating procedure SAS Efficacy Clinical study Biopharmaceutical NIS Elpro SocraTec C&S ANVISA Audit Oncologic network Sore throat Endpoint Quality Auditing OTC Pharmacokinetics Referral system Centralised procedure CDSIC HTA TTS IVIVC HPA axis Highly variable drugs EMA Xerostomia SDV Data management Immunogenicity Pharmacodynamic studies Experience Pharmacology Hypothalamic MDI Degeneration Pharmacokintetics Eye disease Patients Adrenocortical Hormone replacement therapy CRF Project Management IEC Recruitment rates DUS Ophthalmologist GLP Asthma Biopharmaceutics Feasibility AGAH Good Clinical Practice CRO Thuringia Inspection Charcoal Allergy Cardiovascular surveillance Pragmatism Statistical services DPI Patch adhesion Local tolerability PAES DDI HRT Rhine Main area Sequential designs Macular Authorities Subcontractor qualification DFI MCID Quality Assurance In vitro in vivo correlation  
 
Menu

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All fine on front page